Last updated 2026-08-18
- Raised $7.5M Series A led by BATM Advanced Communications Ltd., Oct 2023
- Raised $14.5M Seed round led by Gamida for Life, Feb 2019
Total raised
$22.0M
Stage
—
Founded
2015
Headcount
—
HQ
Limassol, Cyprus
Sector
Medical Devices
About
ADOR Diagnostics develops and manufactures groundbreaking in-vitro multiplex molecular diagnostic solutions designed to immediately diagnose various medical conditions. The company focuses on the NATlab system, an innovative solution for rapid and accurate infectious disease diagnostics at near-patient settings. The system comprises an IP-protected sensor technology with multiple detection spots, a sample-to-answer microfluidic cartridge, and IP-protected isothermal molecular amplification.
Funding history · 2 rounds · $22.0M total
2023-10
A Round
$7.5M
★ BATM Advanced Communications Ltd.new shareholdersexisting shareholdersIsrael Innovation AuthorityBATM Advanced CommunicationsNew and existing shareholdersExisting and new shareholdersother new and existing shareholders
2019-02
Seed
$14.5M
★ Gamida for Life★ Puma Brandenburg Investments★ BATM Advanced Communications★ US medical industry companies★ US medical industry investors
Team · 4
Dr. Zvi Marom
Chairman
Dr. Eran Zahavy
CEO
Dr. Vladimir Hurgin
VP R&D
Nadhim Zahawi
Chairman of Advisory Board
Sectors & technology
Primary sector
Medical Devices
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | adordx.com |
|---|
Identifiers & details
| Founded | 2015 |
|---|